Regions Financial Corp’s Amedisys AMED Stock Holding History

Regions Financial Corp’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-200	Closed	-$25K	–	858
2019 Q1	$25K	Buy	+200	New	+$25.1K	﹤0.01%	1303

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Regions Financial Corp's AMED Position: Q2 2019 in Review

Regions Financial Corp sold out of Amedisys (AMED) in Q2 2019, closing a stake of 200 shares — an estimated $25K sold.

Regions Financial Corp first reported a position in AMED in Q1 2019 and held it in 1 quarter. The position peaked at $25K in Q1 2019. 285 funds tracked by Wall St. Rank hold AMED as of Q2 2019.

Regions Financial Corp reported no remaining Amedisys position as of Q2 2019 after selling out during the quarter.
Regions Financial Corp sold 200 Amedisys shares in Q2 2019, an estimated $25K.
Regions Financial Corp first reported a position in Amedisys in Q1 2019 and held it in 1 quarter.
Regions Financial Corp's Amedisys position peaked at $25K in Q1 2019.
285 funds tracked by Wall St. Rank held Amedisys as of Q2 2019.

Based on Regions Financial Corp's 13F filing for Q2 2019, filed 19 Jul 2019.